Definition
Fecal urgency is the sudden, compelling need to evacuate the bowels that is difficult to defer. It is a symptom rather than a diagnosis and is commonly associated with disorders affecting colonic motility, rectal sensation, or continence mechanisms.
Epidemiology
Fecal urgency is reported in a substantial proportion of individuals with functional bowel disorders, inflammatory bowel disease (IBD), and after certain gastrointestinal surgeries. Prevalence estimates vary by population and underlying condition, ranging from 10% to 40% among patients with irritable bowel syndrome (IBS) and up to 70% in active ulcerative colitis.
Pathophysiology
The sensation of urgency arises from heightened rectal sensitivity (hypersensitivity) and/or rapid colonic transit that delivers stool to the rectum more quickly than normal. Contributing mechanisms may include:
- Inflammation of the colonic mucosa (e.g., IBD) leading to altered neural signaling.
- Dysbiosis or bacterial overgrowth affecting motility patterns.
- Neuromuscular dysfunction of the internal and external anal sphincters.
- Post‑surgical changes such as low anterior resection syndrome after rectal cancer resection.
Common Causes
| Category | Examples |
|---|---|
| Inflammatory | Ulcerative colitis, Crohn’s disease (active colitis) |
| Functional | Irritable bowel syndrome (IBS‑D, IBS‑M), functional diarrhea |
| Infectious | Acute gastroenteritis, Clostridioides difficile infection |
| Medication‑induced | Antibiotics, laxatives, pro‑kinetic agents |
| Post‑surgical | Low anterior resection, ileal pouch‑anal anastomosis |
| Neurological | Spinal cord injury, multiple sclerosis |
| Others | Pelvic floor dyssynergia, rectal prolapse, malignancy |
Clinical Assessment
- History – Onset, frequency, stool characteristics (Bristol stool form), associated pain, blood, weight loss, and relation to meals or triggers.
- Physical Examination – Abdomen and digital rectal examination to assess sphincter tone, presence of masses, or fissures.
- Laboratory Tests – Complete blood count, inflammatory markers (CRP, ESR), stool studies for infection if indicated.
- Imaging/Endoscopy – Colonoscopy, sigmoidoscopy, or imaging (CT/MRI) when structural disease or malignancy is suspected.
- Physiological Testing – Anorectal manometry, balloon expulsion test, or colonic transit studies for refractory cases.
Management
Treat underlying cause when identifiable
- Inflammatory bowel disease – 5‑aminosalicylic acid compounds, corticosteroids, immunomodulators, or biologics per disease severity.
- Infectious etiologies – Targeted antimicrobial therapy.
- Medication review – Discontinue or adjust laxatives, antidiarrheal agents, or offending drugs.
Symptomatic therapy
- Dietary modification – Increase soluble fiber (e.g., psyllium) to bulk stool; reduce irritants (caffeine, spicy foods).
- Antidiarrheal agents – Loperamide or diphenoxylate/atropine for mild to moderate urgency, used cautiously in acute infection.
- Bulking agents – For mixed or irregular stool consistency, to regulate transit.
- Pelvic floor rehabilitation – Biofeedback therapy to improve sphincter coordination in functional cases.
- Neuromodulators – Low‑dose tricyclic antidepressants or selective serotonin reuptake inhibitors may reduce visceral hypersensitivity.
Behavioral strategies
- Timed toileting and “stool training” to establish regular bowel habits.
- Use of rescue pads or protective garments to manage occasional accidents, preserving quality of life.
Prognosis
When fecal urgency is secondary to a treatable condition (e.g., active IBD in remission), symptoms often improve with disease control. In chronic functional disorders, the symptom may persist, but targeted therapy and behavioral interventions can substantially reduce frequency and severity.
Research Directions
Current investigations focus on:
- The role of the gut microbiome in modulating rectal sensitivity.
- Novel agents targeting chloride channels (e.g., lubiprostone) for refractory urgency.
- Advanced neuromodulation techniques (e.g., sacral nerve stimulation) for severe cases unresponsive to conventional therapy.
See also
- Constipation and fecal incontinence
- Irritable bowel syndrome
- Inflammatory bowel disease
References
- Camilleri M. “The Pathophysiology of Functional Bowel Disorders.” Gastroenterology 2020;158(5):1189‑1201.
- Lichtenstein GR, et al. “Management of Crohn’s Disease and Ulcerative Colitis.” Lancet 2022;399:1157‑1169.
- Rao SS, et al. “Guidelines for the Management of Fecal Incontinence.” American Journal of Gastroenterology 2021;116(7):1574‑1589.
- Bharucha AE, et al. “Functional Bowel Disorders.” New England Journal of Medicine 2023;389:974‑985.
This entry reflects current medical knowledge up to June 2026.
